Clinical Trial Update: Fatty Acid Antiarrhythmia Trial (FAAT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial FAAT, sponsored by the National Heart, Lung, and Blood Institute, has completed evaluating a fatty acid–based antiarrhythmic therapy. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Heart Disease
• Ventricular Fibrillation
• Ventricular Tachycardia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arrhythmia, Heart Diseases | Phase 3 | Status: COMPLETED